Takeda Pharmaceuticals announces Japan MAP failure
Takeda Pharmaceuticals has announced that its mutual agreement procedure (MAP) with the National Tax Agency in Japan did not result in an agreement with the US.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: